Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof

Details for Australian Patent Application No. 2007244409 (hide)

Owner TOYAMA CHEMICAL CO., LTD.

Inventors Okuda, Tomohiro; Iwakami, Noboru; Marubuchi, Shigeki

Agent Griffith Hack

Pub. Number AU-B-2007244409

PCT Pub. Number WO2007/125913

Priority 2006-122080 26.04.06 JP

Filing date 24 April 2007

Wipo publication date 8 November 2007

Acceptance publication date 1 December 2011

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/125913 Priority application(s): WO2007/125913

1 December 2011 Application Accepted

  Published as AU-B-2007244409

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007244414-Encapsulated endoscope

2007244368-Antenna unit and receiving system